907991-13-3Relevant articles and documents
An improved synthesis of Lu AA20465
Krafft, Eva A.,Pinard, Emmanuel,Thomas, Andrew W.
, p. 5355 - 5357 (2006)
A solution phase synthesis for the preparation of the glycine transporter 1 (GlyT1) inhibitor Lu AA20465 is presented, which relies on the straightforward assembly of the target molecule through a series of innovative reaction steps. The key steps include a regioselective amination reaction, a chemoselective reduction of an aryl nitro group, a diazotization and iodination sequence under nonaqueous conditions and a copper catalyzed thioarylation reaction.
The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors
Smith, Garrick,Ruhland, Thomas,Mikkelsen, Gitte,Andersen, Kim,Christoffersen, Claus Tornby,Alifrangis, Lene Hjorth,Mork, Arne,Wren, Stephen P.,Harris, Neil,Wyman, Barry M.,Brandt, Guillaume
, p. 4027 - 4030 (2007/10/03)
Elevation of glycine levels and activation of the NMDA receptor by inhibition of the glycine transporter 1 (GlyT-1) is a potential strategy for the treatment of schizophrenia. A novel series of GlyT-1 inhibitors have been identified containing the 2-arylsulfanyl-phenylpiperazine motif. The most prominent member of this series, (R)-4-[5-chloro-2-(4-methoxy-phenylsulfanyl)- phenyl]-2-methyl-piperazin-1-yl-acetic acid (31) is a potent glycine transporter-1 inhibitor (IC50=150nM), which elevated glycine levels in rat ventral hippocampus as measured by microdialysis in vivo at doses of 1.2-4.6mg/kg s.c.